@LauraMeems profile picture
Laura Meems @LauraMeems

MD PhD🇳🇱|👩‍⚕️Cardiology| 👩‍🏫 Postdoc Fellow in Translational Cardiology focusing on Sex differences in Heart Failure, HFpEF Cardio-Obesity. Glutenfree.

Joined January 2009
  • Tweets 1,423
  • Following 209
  • Followers 440
86 Photos and videos
This morning during a combined #AHA #ACC and #ESC session at #ESC2024 I advocated for a new subspecialty of “cardiobesity”. What do you think? Yes ✅ or no 🛑?! @HanCardiomd @escardio @matthewmylee
Michelle Rosenfeld@MichelleR_Heart
1 Sep 2024
❗️At #ESCCongress now: “We may have to conclude BMI is outdated; we need other factors” says @laurameems. She suggests new subspecialty: “cardiobesity” #obesity #CardioTwitter
1
2
6
1,019
Today I gave a talk at #ESC2024 about #glp1ra in #HFpEF. A fully packed room and 12 minutes to talk about new insights. What you missed? ✅ obesity is important, also for cardiologists ✅ glp1RAs are cardioprotective ✅ MoA studies are needed @escardio @HFA_President
5
22
780
#hartfalen in de spotlight tijdens #nationalehartfalenweek! In een interview met @hartinshape en @vrouwenhartspreekt sprak ik over hartfalen, man-vrouw verschillen én onze #hfpef poli in @umcg @CardiologyUmcg @WestenbrinkDaan Benieuwd naar meer? hartinshape.nl/blog/onzichtb…
2
11
499
Ben jij… ✅ een (bijna) arts met ambitie onzichtbaar hartfalen gemakkelijker op te sporen ✅ geïnteresseerd in de nieuwste MRI technieken en cardiologie ✅ een zelfstandige teamspeler die niet bang is om te innoveren Solliciteer dan nu! #phdstudent werkenbijumcg.nl/-/vacatures…

1
2
1
296
Laura Meems retweeted
Cardiology USZ@CardioZurich
10 Dec 2023
📺Esteemed #PCHF Alumni 2022/2023, Congratulations! Your graduation marks the start of your journey as a member of our growing network dedicated to modern #HeartFailure management around the 🌍🌏🌎 heartfailurecourse.com/pchf_… 🙏🏽@JasaityteRuta @david_cm_ @Massimi78530343 @LauraMeems @UZH_en @escardio @HFA_President #HFA_ESC @ESC_President @EJHFEiC @MarcoMetra @WilfriedMullens @ZOLziekenhuis @Uhasselt @FinnGustafsson @CardioZurich @Unispital_USZ @CTECresearch @Steph_Achenbach @MG_Crespo_Leiro @BarandiaranHF @javiercastrodz @ZOLziekenhuis @Uhasselt @GiuseppeGalati_ #HF @_anmco @clara_clarais @GMCRosano @secardiologia @maria_viu @MajaCikes @lamcardio @ShehabAnwer @rmanka_ @Alkadhi_rad @andgiannopmd @HartcentrumH @JessaZiekenhuis @UZH_dsi @GraduateCampus @DQBM_uzh @UZH_ch
0:35
2
14
33
5,365
Laura Meems retweeted
Maja Cikes@MajaCikes
10 Dec 2023
#PCHF Zürich continues to set standards and lead #HeartFailure education in Europe, with a global reach. Congratulations to all of the graduates, faculty and leadership of the course - 5 generations raised, more to come! Honored to be part of this stellar family! 🎓💥🫀📚
1
6
53
3,306
Thank you prof. Marc Pfeffer for your words of wisdom: “Be part of something, you cannot do it by yourself!” And that’s exactly what #PCHF has been: a 2 years course, and a life-long friendship with likeminded HFenthusiasts! #heartfailure #graduation @CardioZurich @escardio
1
10
35
1,624
PCHF module 8: the final module! Looking forward to learn from the giants one more time. Fun, heart failure facts and a final graduation ceremony on Saturday. Let’s get started! @CardioZurich @drsoli4030 @mjschuuring @BarandiaranHF
2
5
16
1,316
Check out this latest study performed at our lab @CardiologyUmcg ! Great example of translational research that holds potential to improve life of PLN-R14del cardiomyopathy patients @HanCardiomd @rudolf_debar
Herman Sillje@HSillje
15 Nov 2023
Exciting breakthroughs in PLN-R14del cardiomyopathy! Our latest research has just been published in Circulation Research. ahajournals.org/doi/10.1161/…
2
5
1,434
Laura Meems retweeted
Eric Topol
@EricTopol
15 Oct 2023
Just published @NatureMedicine Randomized trial of tirzepatide (Mounjaro) vs placebo *after* 12 weeks of intensive lifestyle intervention and >5% weight loss nature.com/articles/s41591-0… At 72 weeks, Placebo group gained 2.5% weight back; GLP-1 drug lost additional 18.4% body weight
20
220
771
284,937
Replying to @CardioZurich
@CardioZurich Module 7 acute #heartfailure was a blast! Some wise words from Prof. @FRuschitzka himself: happiness is the delta between where you are and where you want to be. If the gap is not too wide, you’re doing pretty well! #medtwitter #cardiology
1
7
26
1,810
1
8
456
Weight reduction by #ozempic or #wegovy @nosnieuws. If they would have dig a bit deeper they would have realized it is a DRUG 💊. Quitting this drug without lifestyle changes = weight gain. ✅ breaking a vicious circle ❌ esthetic purposes/ lifelong therapy #doyourhomework
1
284
The word is out #ESC2023: in humans with HFpEF Semaglutide also improves Quality of Life and lowers NTproBNP. Proud that our preclinical studies could be confirmed Gamechanger ⭐️ - #cardioobesity is real!! nejm.org/doi/full/10.1056/NE… @HanCardiomd @MkosiborodMD @AndreasGevaert

Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity | NEJM

Heart failure with preserved ejection fraction is increasing in prevalence and is associated with a high symptom burden and functional impairment, especially in persons with obesity. No therapies h...

nejm.org
8
300
Frustrerend deze advertentie in @LINDAmagazine over afvallen met #Semaglutide (#Ozempic). 1. Het is #medicijn, geen quick-fix 2. Game changer in obesitas 🏥 ☠️ 3. Amper leverbaar vanwege grondstof tekort @_LindadeMol volgend nummer tekst en uitleg over dit nieuwe medicijn?
3
321
Yes, semaglutide has beneficial effects in humans as well! Our results in preclinical HFpEF published earlier this months suggested benefit. Very pleased to see that it’s potential in humans without HFpEF. Counting off the days to ESC! @novonordisk @AadVoerder #cardioobesity
Henry Han
@HanCardiomd
8 Aug 2023
#Semaglutide 2.4 mg reduces the risk of MACE by 20% in adults with overweight or obesity in the #SELECT trial SELECT study baseline characteristics 👇🏻 onlinelibrary.wiley.com/doi/… @novonordisk announced the headline results from the SELECT CV outcomes trial. 👇🏻 novonordisk.com/content/nnco… Novo Nordisk expects to file for regulatory approvals of a label indication expansion for semaglutide 2.4 mg (Wegovy®) in the US and the EU in 2023.
1
6
600
Laura Meems retweeted
Henry Han
@HanCardiomd
8 Aug 2023
#Semaglutide 2.4 mg reduces the risk of MACE by 20% in adults with overweight or obesity in the #SELECT trial SELECT study baseline characteristics 👇🏻 onlinelibrary.wiley.com/doi/… @novonordisk announced the headline results from the SELECT CV outcomes trial. 👇🏻 novonordisk.com/content/nnco… Novo Nordisk expects to file for regulatory approvals of a label indication expansion for semaglutide 2.4 mg (Wegovy®) in the US and the EU in 2023.
1
41
107
14,629
Laura Meems retweeted
UMCG Cardiology Research Institute@CardiologyUmcg
31 Jul 2023
#1 🐭💓 A new preclinical study from our institute ! @AadWithaar and @LauraMeems explored semaglutide in the context of #HFpEF @rudolf_deboer #MondayScientificSnack
2
3
5
502
Available online as per today - a preclinical study on the cardio protective effects of Semaglutide in HFpEF mice! 🧵 jacc.org/doi/10.1016/j.jacbt…
1
7
20
2,141
more replies
3. Result? Weight loss alone is not enough!Semaglutide 💊 = better cardiometabolic profile, cardiac structure, and cardiac Fx. Transcriptomics proteomics 🧬 = improved left ventricular cytoskeleton Fx & endothelial Fx restored protective immune responses in visceral fat.
1
2
144
4. In conclusion, In HFpEF mice Semaglutide is better than fat reduction by dietary intervention! Looking forward to human data from #STEPHFpEF presented #ESC2023 @escardio @rudolf_deboer @HanCardiomd @_antocannata @AndreasGevaert @MkosiborodMD
3
210
Load more